LGALS3 and myocardial infarction: Investigations of Gal-3 and NT-proBNP have been conducted in a variety of cardiac diseases, such as heart failure, myocardial fibrosis, atrial fibrosis, myocardial infarction, ischemic cardiomyopathy [11], [12], [13].